BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for NOVUS THERAPEUTICS INC (NVUS)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for NOVUS THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-02-16
4:17 pm
Sale		2020-12-3113GNOVUS THERAPEUTICS INC
NVUS		BIOTECHNOLOGY VALUE FUND L P1,503,121
9.990%		-14,918decrease
(-0.98%)		Filing
2020-12-30
5:27 pm
Purchase		2020-12-2813GNOVUS THERAPEUTICS INC
NVUS		BIOTECHNOLOGY VALUE FUND L P1,518,039
10.000%		3,520increase
(+0.23%)		Filing
2020-12-28
5:13 pm
Purchase		2020-12-2213GNOVUS THERAPEUTICS INC
NVUS		BIOTECHNOLOGY VALUE FUND L P1,514,519
9.990%		1,319,193increase
(+675.38%)		Filing
2020-10-05
5:26 pm
Purchase		2020-10-0113GNOVUS THERAPEUTICS INC
NVUS		BIOTECHNOLOGY VALUE FUND L P195,326
15.600%		195,326increase
(New Position)		Filing